Nov 12, 2020, 17:31 ET
NEW YORK, Nov. 12, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Jaws Acquisition Corp. ("JWS" or the "Company") (NYSE: JWS) in connection with the Company's proposed merger with privately-held healthcare provider Cano Health, LLC ("Cano"). Under the terms of the merger agreement, JWS will acquire Cano through a reverse merger that will result in Cano becoming a public company traded on the New York Stock Exchange under the new ticker symbol "CANO." The transaction is expected to have an enterprise value of approximately $4.4 billion on a pro forma basis.
If you own JWS shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
Or please contact:
Joshua Rubin, Esq.
1500 Broadway, 16th Floor
New York, NY 10036
WeissLaw is investigating whether JWS's board acted in the best interest of JWS's public stockholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of Cano, and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to JWS's public stockholders.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]
SOURCE WeissLaw LLP
Share this article